CAMBRIDGE, Mass., March 4, 2013 /PRNewswire/ -- GNS Healthcare today announced that it has joined in the formation of Orion Bionetworks. This unique alliance will work to transform our understanding of and accelerate the drug development process for a wide variety of diseases, beginning with multiple sclerosis (MS). Using patient data from alliance members Accelerated Cure Project for Multiple Sclerosis, the Institute for Neurosciences at Brigham and Women's Hospital, and PatientsLikeMe, GNS will build powerful, predictive, computational models to yield new information about the disease, which will pave the way for more effective treatments for patients and the discovery of new therapies and cures. The initial phase of this effort is made possible by a $5.4 million commitment by Janssen Research & Development, a subsidiary of Johnson & Johnson.
Other crucial alliance groups include the Marin Community Foundation, MetaCell, and program sponsors and supporting partners One Mind for Research, Morrison & Foerster, Recombinant Data and Weber Shandwick. Through Orion Bionetworks, these alliance members will use cutting-edge technology to greatly expand our body of knowledge of diseases, prevention, and treatments.
"In order to leverage the power of computational modeling to predict health outcomes, you first need access to a large set of data to analyze, which is e
|SOURCE GNS Healthcare|
Copyright©2012 PR Newswire.
All rights reserved